Suppression of Multiclade R5 and X4 Human Immunodeficiency Virus Type-1 Infections by a Coreceptor-Based Anti-HIV Strategy
Authors:
- Shogo MisumiSMShogo Misumi
- Ryouzaburo MukaiRMRyouzaburo Mukai
- Kuniomi TachibanaKTKuniomi Tachibana
- Mamoru UmedaMUMamoru Umeda
- Hideaki ShibataHSHideaki Shibata
- Nobutoki TakamuneNTNobutoki Takamune
- Shozo ShojiSSShozo Shoji
- 1 November 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 138 (5) , 571-582
Abstract
A cyclic chimeric dodecapeptide (cCD) mimicking the conformation-specific domains of CCR5 and CXCR4 was prepared in which Gly-Asp links the amino and carboxyl termini of two combined pentapeptides (S169–G173 of CCR5; E179-R183 of CXCR4) derived from human immunodeficiency virus type-1 (HIV-1) coreceptors. The immunization of Balb/c mice with cCD conjugated with a multiple-antigen peptide (cCD-MAP) induced seven cCD-specific monoclonal antibodies (mAbs, CPMAb-I to -VII) that reacted with native CCR5 and CXCR4. Among the tested mAbs, CPMAb-I and -II potently inhibited the infection of both the R5 and X4 laboratory strains. CPMAb-III and -VI were effective against only R5 laboratory strains, and also against some X4 and R5 primary isolates. CPMAb-IV and -V had potent antiviral activities against the R5 and X4 primary isolates. In particular, CPMAb-VII was protective against not only R5 and X4 laboratory strains, but also most of the R5 and X4 primary isolates. Moreover, cCD-MAP immunization also induced antibodies that were effective against R5 and X4 multiclade HIV-1 isolates in vitro in two of three cynomolgus monkeys. Taken together, the results suggest that cCD-MAP is a candidate multiclade immunogen that can be used to block multiclade R5 and X4 HIV-1 infections.Keywords
This publication has 40 references indexed in Scilit:
- Rapid evolution of the neutralizing antibody response to HIV type 1 infectionProceedings of the National Academy of Sciences, 2003
- Human Immunodeficiency Virus Type 1 Subtype C Molecular Phylogeny: Consensus Sequence for an AIDS Vaccine Design?Journal of Virology, 2002
- Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytesNature, 2002
- A Cyclic Dodecapeptide–Multiple-Antigen Peptide Conjugate from the Undecapeptidyl Arch (from Arg 168 to Cys 178 ) of Extracellular Loop 2 in CCR5 as a Novel Human Immunodeficiency Virus Type 1 VaccineJournal of Virology, 2001
- Evidence as a HIV-1 Self-Defense Vaccine of Cyclic Chimeric Dodecapeptide Warped from Undecapeptidyl Arch of Extracellular Loop 2 in Both CCR5 and CXCR4Biochemical and Biophysical Research Communications, 2001
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- A new classification for HIV-1Nature, 1998
- Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected IndividualsJournal of Experimental Medicine, 1997
- Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDSNature Medicine, 1997
- HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled ReceptorScience, 1996